Abstract:γ-Aminobutyric acid (GABA) has been widely used in the food, feed, pharmaceutical, and chemical industry fields. Previously, we developed a whole-cell catalyst capable of converting L-glutamate (L-Glu) into GABA by overexpressing the glutamate decarboxylase gene ( gadz11 ) from Bacillus sp. Z11 in Escherichia coli BL21(DE3). However, to enhance cell permeability, a freeze-thaw treatment is required, and to enhance GADZ11 activity, pyridoxal 5'-phosphate (PLP) must be added to the reaction system. The aim of this study is to provide a more efficient approach for GABA production by engineering the recombinant E. coli above. First, the inducible expression conditions of the gadz11 in E. coli were optimized to 37 °C for 6 h. Next, an ideal engineered strain was produced via increasing cell permeability by overexpressing sulA and eliminating PLP dependence by constructing a self-sufficient system. Furthermore, an efficient whole-cell biocatalytic process was optimized. The optimal substrate concentration, cell density, and reaction temperature were 1.0 mol/L (the molecular ratio of L-Glu to L-monosodium glutamate (L-MSG) was 4:1), 15 and 37 °C, respectively. Finally, a whole-cell bioconversion procedure was performed in a 3-L bioreactor under optimal conditions. The strain could be reused for at least two cycles with GABA yield, productivity and conversion ratio of 206.2 g/L, 117.8 g/L/h and 100.0%, respectively. This is currently the highest GABA productivity from a mixture of L-Glu and L-MSG reported without the addition of cofactors or additional treatment of cells. This work demonstrates that the novel engineered E. coli strain has the potential for application in large-scale industrial GABA production.

A tri‐enzyme cascade for efficient production of L‐2‐aminobutyrate from L‐threonine

Enhancement of Abscisic Acid Biosynthesis in Saccharomyces Cerevisiae Via Multidimensional Engineering

Biocatalytic Asymmetric Synthesis of L-Phosphinothricin Using a One-Pot Three Enzyme System and a Continuous Substrate Fed-Batch Strategy

Artificial Biocatalytic Cascade with Three Enzymes in One Pot for Asymmetric Synthesis of Chiral Unnatural Amino Acids

Increased productivity of l -2-aminobutyric acid and total turnover number of NAD + /NADH in a one-pot system through enhanced thermostability of l -threonine deaminase

Development of a fermentation strategy to enhance the catalytic efficiency of recombinant Escherichia coli for l-2-aminobutyric acid production

Multi-enzyme cascade for improving β-hydroxy-α-amino acids production by engineering L-threonine transaldolase and combining acetaldehyde elimination system

Highly selective synthesis of d-amino acids via stereoinversion of corresponding counterpart by an in vivo cascade cell factory

Efficient Synthesis of D‐Phenylalanine from L‐Phenylalanine via a Tri‐Enzymatic Cascade Pathway

Expanding metabolism for total biosynthesis of the nonnatural amino acid L-homoalanine

Expanding the L-threonine transaldolase toolbox for the diastereomeric synthesis of β‐hydroxy-α-amino acids

Enhanced production of β-alanine through co-expressing two different subtypes of L-aspartate-α-decarboxylase

[Efficient biosynthesis of guanidoacetic acid by a recombinant strain of Bacillus subtilis]

Efficient biosynthesis of D/L-alanine in the recombinant Escherichia coli BL21(DE3) by biobrick approach

Production of β‐Alanine from Fumaric Acid Using a Dual‐Enzyme Cascade

Efficient biosynthesis of α‐aminoadipic acid via lysine catabolism in Escherichia coli

Co-immobilized Multienzyme System for the Cofactor-Driven Cascade Synthesis of ( R ) - 2-Amino-3-(2-bromophenyl)propanoic Acid: A Model Reaction

Engineering acetylation platform for the total biosynthesis of D-amino acids

Efficient Production of γ-Aminobutyric Acid Using Engineered Escherichia coli Whole-Cell Catalyst

Construction of an enzymatic-chemical cascade involving engineered amine dehydrogenases for the synthesis of chiral non- α -amino acids by substrate engineering and enzyme evolution

One-pot enantioselective synthesis of chiral phenyllactic acids by combining stereocomplementary d- and l-lactate dehydrogenases with multi-enzyme expression fine-tuning